Sparc Life
Yogin Vaidya is an experienced professional in the field of drug discovery, currently serving as an Executive at Sun Pharma Advanced Research Company Ltd. since September 2020. Previously, Yogin worked as a Postgraduate Researcher at The Maharaja Sayajirao University of Baroda from May 2019 to July 2020, focusing on synthesizing and characterizing D-pi-A heterocyclic conjugated molecules for potential use in dye-sensitized solar cells. Yogin holds a Master of Science in Organic Chemistry and a Bachelor of Science in Chemistry (Hons.) from The Maharaja Sayajirao University of Baroda.
This person is not in any teams
This person is not in any offices
Sparc Life
SPARC (NSE: SPARC; BSE: 532872) is a biopharmaceutical company continuously innovating new therapies in oncology, neurodegeneration, and immunology. SPARC's value proposition lies in our brick-and-mortar infrastructure to effectively translate therapies from the bench, through clinical studies, to regulatory approval. This engine has resulted in approval of two NDAs. Our approved products are marketed by our commercial partners in the US, China, and India. We are 400+ strong team spread across three global locations, with a vibrant research community of 350+ scientists working on a robust pipeline of clinical and preclinical programs. Our teams' strengths span the R&D spectrum: small and large molecule drug discovery; CMC development; preclinical translation (including NDA-enabling toxicology); and clinical development and operations. All of this makes SPARC unique among other small biopharma companies, especially single-asset or single-therapy focused companies. We continue to build and strengthen our innovation engine with emphases on strong scientific execution, high value analytics, and aggressive portfolio management, to redefine patient care in areas of unmet need.